These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4947805)

  • 1. A quantitative study of neuroleptic-induced extrapyramidal symptoms and their response to dexetimide, a potent and long-acting antiparkinsonian agent.
    Dom R; Van Lommel R; Baro F
    Acta Psychiatr Scand; 1971; 47(4):399-410. PubMed ID: 4947805
    [No Abstract]   [Full Text] [Related]  

  • 2. Dexetimide: an effective drug for the control of extrapyramidal symptoms induced by pipothiazine palmitate.
    Dom R; Van Lommel R; Baro F
    Acta Psychiatr Scand; 1973; 49(5):563-9. PubMed ID: 4148581
    [No Abstract]   [Full Text] [Related]  

  • 3. Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action.
    Huygens H; Vereecken JL; Tanghe A
    Psychiatr Neurol Neurochir; 1973; 76(4):251-9. PubMed ID: 4581374
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
    Neu C; Dimascio A; Demirgian E
    Curr Ther Res Clin Exp; 1972 May; 14(5):246-51. PubMed ID: 4623975
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics.
    Klett CJ; Caffey E
    Arch Gen Psychiatry; 1972 Apr; 26(4):374-9. PubMed ID: 4552131
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticholinergic prophylaxis of acute haloperidol-induced acute dystonic reactions.
    Boyer WF; Bakalar NH; Lake CR
    J Clin Psychopharmacol; 1987 Jun; 7(3):164-6. PubMed ID: 3597801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pridinolum mesylate and neuroleptic malignant syndrome.
    Giordani L; Amore M; Montanari A; Berlinzani L; Gentili C
    Am J Psychiatry; 1985 Mar; 142(3):389-90. PubMed ID: 3970286
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of benztropine mesylate and amantadine HCl in neuroleptic-induced extrapyramidal symptoms.
    Stenson RL; Donion PT; Meyer JE
    Compr Psychiatry; 1976; 17(6):763-8. PubMed ID: 791573
    [No Abstract]   [Full Text] [Related]  

  • 9. Meige syndrome: relief on high-dose anticholinergic therapy.
    Duvoisin RC
    Clin Neuropharmacol; 1983 Mar; 6(1):63-6. PubMed ID: 6850651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethylbenzatropine for acute neurological and mental side effects after tranquillisers.
    Molcan J; Floreánová L; Polák L
    Act Nerv Super (Praha); 1972; 14(2):97. PubMed ID: 5040183
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and ergotherapeutic evaluation of fluspirilene (R 6218), a long-acting injectable neuroleptic, in chronic psychotic patients.
    Tanghe A; Vereecken JL
    Psychiatr Neurol Neurochir; 1971; 74(5):379-89. PubMed ID: 5138128
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversal of some therapeutic effects of an antipsychotic agent by an antiparkinsonism drug.
    Singh MM; Smith JM
    J Nerv Ment Dis; 1973 Jul; 157(1):50-8. PubMed ID: 4713306
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug induced extrapyramidal effects--a review.
    Coleman JH; Hayes PE
    Dis Nerv Syst; 1975 Oct; 36(10):591-3. PubMed ID: 1100334
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous benzotropine mesylate challenge in acute neuroleptic-induced dystonia.
    al Jeshi A; al Kaisi HH
    Can J Psychiatry; 1998 Feb; 43(1):85-6. PubMed ID: 9494754
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiparkinsonian agents and depot phenothiazine.
    Chien CP; Dimascio A; Cole JO
    Am J Psychiatry; 1974 Jan; 131(1):86-90. PubMed ID: 4808437
    [No Abstract]   [Full Text] [Related]  

  • 16. Neutralization of extrapyramidal side-effects with Methixene.
    Maller O; Heller S
    Dis Nerv Syst; 1971 Jun; 32(6):409-15. PubMed ID: 5570695
    [No Abstract]   [Full Text] [Related]  

  • 17. [A new synthetic antiparkinsonian drug, tropatepine hydrochloride in extrapyramidal syndromes induced by neuroleptics].
    Lambert A; dachary JM; Marie C; Oules J; Pagot R; Sales M; Vauterin C
    Encephale; 1976; 2(2):115-21. PubMed ID: 776591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depot phenothiazine treatment in acute psychosis: a sequential comparative clinical study.
    Chien CP; Cole JO
    Am J Psychiatry; 1973 Jan; 130(1):13-8. PubMed ID: 4566388
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of extrapyramidal side effects induced by neuroleptics.
    Tune LE; McHugh PR; Coyle JT
    Johns Hopkins Med J; 1981 Mar; 148(3):149-53. PubMed ID: 7206408
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical study of a new agent correcting the syndrome of neuroleptic impregnation in acute psychotic states].
    Vauterin C; Veillon F
    Encephale; 1975; 1(1):61-8. PubMed ID: 1093847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.